ScholarLens Back to search
2013•Chinese Journal of OsteoporosisRequires access

Strontium ranelate: an anti-osteoporotic drug with dual effects

Tianli Ren

Open publisher page 0 citations

Abstract

Unlike other anti-osteoporotic drugs,strontium ranelate(SR) is a novel anti-osteoporotic drug,which has unique dual effects on bone metabolism,including inhibiting bone resorption and promoting bone formation.SR can alter the bone microstructure,and increase the bone mineral density and bone strength.Thus,SR can reduce the risk of fractures and improve the life quality of the patients.Clinical researches reveal that SR can reduce the risk of vertebral and non-vertebral fractures in patients with postmenopausal osteoporosis.The effect of SR can maintain for a long time.The safety and tolerance of SR are good.

About this research paper

What this paper is about

Unlike other anti-osteoporotic drugs,strontium ranelate(SR) is a novel anti-osteoporotic drug,which has unique dual effects on bone metabolism,including inhibiting bone resorption and promoting bone formation.SR can alter the bone microstructure,and increase the bone mineral density and bone strength.Thus,SR can reduce the risk of fractures and improve the life quality of the patients.Clinical researches reveal that SR can reduce the risk of vertebral and non-vertebral fractures in patients with postmenopausal osteoporosis.The effect of SR can maintain for a long time.The safety and tolerance of SR are good.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Unlike other anti-osteoporotic drugs,strontium ranelate(SR) is a novel anti-osteoporotic drug,which has unique dual effects on bone metabolism,including inhibiting bone resorption and promoting bone formation.SR can alter the bone microstructure,and increase the bone mineral density and bone strength.Thus,SR can reduce the risk of fractures and improve the life quality of the patients.Clinical researches reveal that SR can reduce the risk of vertebral and non-vertebral fractures in patients with postmenopausal osteoporosis.The effect of SR can maintain for a long time.The safety and tolerance of SR are good.

Key concepts: Strontium ranelate, Osteoporosis, Medicine, Bone mineral, Bone resorption, Bone remodeling, Bone Density Conservation Agents, Dentistry

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Strontium ranelate: an anti-osteoporotic drug with dual effects — Research Paper | ScholarLens